Dendrite International and Eli Lilly Sign Comprehensive Services Agreement
Dendrite International, a global provider of specialized sales and marketing solutions for the pharmaceutical and consumer package goods (CPG) industries, has announced a comprehensive services agreement with Eli Lilly and Company, a leading global research-based pharmaceutical corporation. This agreement is designed to support Lilly's US sales and management teams, building on the global license agreement signed by the two companies in April of this year. The new agreement will see Dendrite provide tailored services to Lilly's locations in several countries, including Canada, the Netherlands, New Zealand, Norway, Sweden, and the United Kingdom, with more announcements expected.
Key Takeaways:
- Dendrite International and Eli Lilly and Company have signed a comprehensive services agreement to support Lilly's US sales and management teams.
- The agreement is a result of the global license agreement signed by the two companies in April of this year.
- Dendrite's support services will be contracted by Lilly locations in Canada, the Netherlands, New Zealand, Norway, Sweden, and the United Kingdom, with more announcements expected.
- Dendrite's services will help Lilly's sales teams prepare for tomorrow's challenges and improve their sales success.
- Dendrite's commitment to unparalleled service has been the hallmark of the business and the basis of strong customer loyalty since its inception in 1986.
- Headquartered in Morristown, New Jersey, Dendrite employs over 1100 people around the world.
- Dendrite is a registered trademark of Dendrite International, Inc.
Statistics:
- Over 1100 people are employed by Dendrite around the world.
- Dendrite supports sales representatives and their managers from over 150 companies and 57 countries.
- Dendrite's global infrastructure is the foundation of its business.
- 57 countries are represented in Dendrite's global customer base.
- 1986 - the year Dendrite was founded.
Sources:
- This press release may contain statements that, if not verifiable historical fact, may be viewed as forward-looking statements that could predict future events or outcomes with respect to Dendrite and its business.
- http://www.drte.com - Dendrite International's Web site.
- NASDAQ/NMS:DRTE - Dendrite International, Inc.'s stock ticker symbol.
- LILLY - Eli Lilly and Company's stock ticker symbol.
- Eli Lilly and Company's Web site.
Note: All sources are cited exactly as mentioned in the original text, and no dates or details have been added.